Stock exchange release:
Borregaard’s operating revenues reached NOK 1,429 million (NOK 1,260 million)² in the 3 rd quarter of 2021. EBITDA¹ increased to NOK 391 million (NOK 266 million). BioSolutions’ result improved significantly. Fine Chemicals also improved, whereas BioMaterials had a result in line with last year. The net currency impact on EBITDA was slightly positive compared with the 3 rd quarter of 2020.
The continued impact from increased sales prices and a favourable product mix were the main reasons for the EBITDA improvement in BioSolutions. For BioMaterials, high deliveries and reduced wood costs compensated for reduced sales prices and increased energy costs. High sales volume and increased sales price for bioethanol contributed to the improvement in Fine Chemicals. High spot prices for liquefied natural gas and electricity led to increased energy costs in all business areas.
Profit before tax was NOK 269 million (NOK 133 million). Earnings per share was NOK 2.12 (NOK 1.12).
- We are pleased both with the result improvement and the strong performance in BioSolutions. Generally, the markets were strong for all business segments, says President and CEO Per A. Sørlie.
Contacts:
Director Investor Relations, Jørn Syvertsen, +47 958 36 335
Director Communication, Tone Horvei Bredal, +47 924 67 711
1. Operating profit before depreciation, amortisation and other income and expenses
2. Figures in parentheses are for the corresponding period in the preceding year
This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.
Borregaard reported third quarter 2021 results on Thursday 21 October 2021 at 07:00 CET.